Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Gossard

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Biopharmaceutics & Drug Disposition|December 1, 1993
Comparative pharmacokinetics and pharmacodynamics of two marketed bid formulations of diltiazem in healthy volunteersS Guimont, H Landriault, K Klischer, et al.
The American Journal of Psychiatry|April 1, 1986
Ambulatory heart rate changes in patients with panic attacksC B Taylor, J Sheikh, W S Agras, et al.
American Heart Journal|May 1, 1995
Long-term risk stratification with dipyridamole imagingJ Lette, C Bertrand, D Gossard, et al.
Biopharmaceutics & Drug Disposition|May 1, 1997
Pharmacokinetics and safety of single intravenous and oral doses of dolasetron mesylate in healthy womenA C Keung, H Landriault, M Lefebvre, et al.
The American Journal of Cardiology|February 15, 1986
Effects of low- and high-intensity home-based exercise training on functional capacity in healthy middle-aged menD Gossard, W L Haskell, C B Taylor, et al.
JAMA|July 8, 1988
Early return to work after uncomplicated myocardial infarction. Results of a randomized trialC Dennis, N Houston-Miller, R G Schwartz, et al.
The American Journal of Cardiology|February 15, 1986
Assessment of prescribed increases in physical activity: application of a new method for microprocessor analysis of heart rateJ K Mueller, D Gossard, F R Adams, et al.
Psychiatry Research|April 1, 1986
Lactate infusions and panic attacks: do patients and controls respond differently?A Ehlers, J Margraf, W T Roth, et al.
Clinical Pharmacology and Therapeutics|November 22, 2007
Combination of phenotype assessments and CYP2C9-VKORC1 polymorphisms in the determination of warfarin dose requirements in heavily medicated patientsV Michaud, M-C Vanier, D Brouillette, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Biopharmaceutics & Drug Disposition|December 1, 1993
Comparative pharmacokinetics and pharmacodynamics of two marketed bid formulations of diltiazem in healthy volunteersS Guimont, H Landriault, K Klischer, et al.
The American Journal of Psychiatry|April 1, 1986
Ambulatory heart rate changes in patients with panic attacksC B Taylor, J Sheikh, W S Agras, et al.
American Heart Journal|May 1, 1995
Long-term risk stratification with dipyridamole imagingJ Lette, C Bertrand, D Gossard, et al.
Biopharmaceutics & Drug Disposition|May 1, 1997
Pharmacokinetics and safety of single intravenous and oral doses of dolasetron mesylate in healthy womenA C Keung, H Landriault, M Lefebvre, et al.
The American Journal of Cardiology|February 15, 1986
Effects of low- and high-intensity home-based exercise training on functional capacity in healthy middle-aged menD Gossard, W L Haskell, C B Taylor, et al.
JAMA|July 8, 1988
Early return to work after uncomplicated myocardial infarction. Results of a randomized trialC Dennis, N Houston-Miller, R G Schwartz, et al.
The American Journal of Cardiology|February 15, 1986
Assessment of prescribed increases in physical activity: application of a new method for microprocessor analysis of heart rateJ K Mueller, D Gossard, F R Adams, et al.
Psychiatry Research|April 1, 1986
Lactate infusions and panic attacks: do patients and controls respond differently?A Ehlers, J Margraf, W T Roth, et al.
Clinical Pharmacology and Therapeutics|November 22, 2007
Combination of phenotype assessments and CYP2C9-VKORC1 polymorphisms in the determination of warfarin dose requirements in heavily medicated patientsV Michaud, M-C Vanier, D Brouillette, et al.
Pageof 2